The Department of Justice reached a settlement with the Cleveland Clinic over pediatric gender-transition treatments, joining a recent agreement with Texas Children’s Hospital and signaling a coordinated federal effort to halt medical interventions for minors. The Cleveland Clinic will stop offering puberty blockers and cross-sex hormones to children, commit $2 million to detransition care, and pay $308,000 to resolve billing allegations, while the DOJ framed both settlements as part of enforcing federal law around these practices.
The DOJ announced the Cleveland Clinic agreement alongside Ohio officials, saying the hospital made a long-term commitment not to perform or offer what the settlement calls “sex-rejecting procedures” on minors. Associate Attorney General Stanley Woodward characterized the move as part of a broader enforcement push, noting the department’s intent to intervene when children are at risk from pediatric gender-transition interventions.
The settlement follows the mid-May resolution with Texas Children’s Hospital, which agreed to pay $10 million, stop pediatric gender-transition procedures, and create a detransition clinic described by the DOJ as the nation’s first dedicated center for those who reverse transition treatments. Those actions together show federal officials pressing major health systems to change course on care for minors, and they reflect the concerns many conservative families and advocacy groups have raised about experimental treatments for youth.
The DOJ said the Cleveland Clinic would resolve allegations that it used billing practices to secure insurance coverage for pediatric gender-transition procedures, though the department emphasized those matters are alleged and that the hospital denied wrongdoing. Critics for months have warned that some providers may use diagnosis coding to obtain reimbursement for interventions that otherwise might not meet coverage standards, and nonprofit researchers have published analyses pointing to coding practices that obscure treatment purposes.
“The Department of Justice is steadfastly committed to protecting America’s children. Just as the resolution with Texas Children’s, today’s resolution with Cleveland Clinic furthers that commitment and puts these providers on notice that this Department will vigorously enforce federal law where children are put at risk.”
Advocacy groups and watchdogs who campaigned against pediatric transition programs hailed the settlement as a vindication of their work. Consumers’ Research, which ran a public campaign targeting the Cleveland Clinic, framed the agreement as an admission that the hospital performed interventions on minors and said the settlement forces the system to stop those practices, fund detransition support, and pay a federal penalty.
“Consumers’ Research exposed the Cleveland Clinic for performing transgender interventions on children, and the Cleveland Clinic responded with threatened legal action, saying our campaign was riddled with lies. Now, thanks to the Department of Justice, Cleveland Clinic has been forced to admit they were performing sex change interventions on kids and agreed to permanently end these dangerous procedures, pay a federal penalty, and fund millions in care for the children they harmed.”
Medical critics also interpreted the settlement as backing concerns about the long-term impacts of pediatric gender-transition care. Do No Harm, a group of health professionals opposing what it calls the politicization of medicine, argued that the agreement validates findings from their report detailing how billing and diagnostic coding may have been used to facilitate coverage of these interventions for minors.
“This is a momentous victory for detransitioners and evidence-based medicine. While no amount of money will undo the harms pediatric gender-transition procedures have caused victims, this settlement provides millions of dollars to support medical care for detransitioners and importantly resolves allegations of fraudulent billing, a tactic outlined in our recent report.”
The Cleveland Clinic pushed back, saying it already provided detransition services and describing the billing concerns as an unintentional coding issue affecting a small number of patients. The hospital also noted state law restricts pediatric gender-transition treatments in Ohio and emphasized it will continue gender-transition services for adults, drawing a legal line between care for minors and care for consenting adults.
Federal officials framed both settlements as components of a larger campaign to scrutinize and curb pediatric gender-transition care across the country. With two of the nation’s largest hospital systems agreeing to halt these procedures for minors, advocates on the conservative side expect additional institutions may face similar pressure or investigations in the months ahead.
Beyond enforcement, the settlements include concrete financial commitments intended to address past patients’ needs, with the Cleveland Clinic agreeing to $2 million for detransition care and a separate civil payment of $308,000. Those commitments are meant to fund medical follow-up and support services for individuals who received transition-related care as minors, a key point cited by both critics and officials when discussing remediation for harmed patients.
The ongoing federal attention to pediatric gender-transition practices raises questions about how hospitals will align clinical policy, coding practices, and state laws going forward. For families and providers, the settlements mark a clear signal that the federal government will continue to scrutinize how care for minors is coded, billed, and delivered, especially when it comes to irreversible medical interventions.
Add comment